Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | BRAF |
Variant | W531C |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | BRAF W531C lies within the protein kinase domain of the Braf protein (UniProt.org). W531C results in the weak activation of MEK signaling and does not induce transformation in cell culture (PMID: 19206169), but in two different cell lines, W531C demonstrates increased cell proliferation and viability as compared to wild-type Braf (PMID: 29533785), and demonstrates increased Mek and Erk signaling in drosophila (PMID: 33855281), and therefore, its effect on Braf protein function is unknown. |
Associated Drug Resistance | |
Category Variants Paths |
BRAF mutant BRAF W531C |
Transcript | NM_004333.6 |
gDNA | chr7:g.140777013C>A |
cDNA | c.1593G>T |
Protein | p.W531C |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_004333 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_001378474.1 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
XM_005250045 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_004333.6 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_004333.5 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_001378475.1 | chr7:g.140753278C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
XM_047420769.1 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_001378468.1 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_001354609.2 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
NM_001354609.1 | chr7:g.140777013C>A | c.1593G>T | p.W531C | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|